Vical elects George J. Morrow to the board
Article continues below
Mr. Morrow joined Amgen in 2001 as Executive Vice President, Worldwide Sales and Marketing, and advanced to Executive Vice President, Global Commercial Operations, a position he held until his retirement.
Mr. Morrow also held executive management and commercial positions within several subsidiaries of Glaxo Wellcome, including Group Vice President for Commercial Operations U.S., Managing Director U.K., and President and Chief Executive Officer of Glaxo Wellcome U.S.. His prior experience at Merck include sales and marketing positions culminating as Vice President of Marketing.
Mr. Morrow is a member of the Board of Directors of Align Technology, and was a member of the Board of Directors of Human Genome Sciences until its acquisition by GlaxoSmithKline. He has served previously on boards for Glaxo Wellcome, the Johns Hopkins School of Public Health, and the Duke University Fuqua School of Business. ■